http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200066921-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55a854abe5a37b075d9a25a1cfcb46eb |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2018-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f413be162bede5ebdd6a99032f870b9d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5436d393087e66223a44db6c2cda78b5 |
| publicationDate | 2020-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20200066921-A |
| titleOfInvention | Composition for predicting radio-resistance or radio-sensitive ROMO1 marker and use thereof |
| abstract | The present invention relates to a composition for predicting radiation resistance or susceptibility, including an agent for measuring ROMO1, and a use thereof. When using the composition for predicting radiation resistance or susceptibility including the formulation for measuring ROMO1 of the present invention, as a result of analyzing Romo1 expression of various cancer cells irradiated with radiation, it was confirmed that radiation resistance appeared in cancer cells having high ROMO1 expression. In addition, as a result of analyzing the expression of ROMO1 in lung cancer patients who received radiation therapy, it was confirmed that the high expression group of the ROMO1 protein classified as a specific cut-off value had many recurrences, and the survival time was significantly shortened. Since it has a predictable effect on the sensitivity and resistance of cancer cells, it can be usefully used in related industries. |
| priorityDate | 2018-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 95.